Idarucizumab for Dabigatran Reversal — Full Cohort AnalysisCharles V. Pollack, Jeffrey I. Weitz, Paul Reilly et al.|New England Journal of Medicine|2017Cited by 1.1k
A specific antidote for dabigatran: functional and structural characterizationFelix Schiele, Tobias Litzenburger, Joanne van Ryn et al.|Blood|2013Cited by 562
The Discovery of Dabigatran EtexilateJoanne van Ryn, Andreas Clemens, Norbert Hauel et al.|Frontiers in Pharmacology|2013Cited by 71
Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregationThomas Vanassche, Peter Verhamme, Alexandre Kauskot et al.|Thrombosis and Haemostasis|2012Cited by 66
Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulenceThomas Vanassche, Peter Verhamme, Jan Verhaegen et al.|Journal of Thrombosis and Haemostasis|2011Cited by 61